| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
May 5,
2026 |
| Accession Number: |
0001178913-26-002360 |
| Submission Type: |
POS AM |
| CIK: |
0001553846 |
| Company Name: |
RedHill Biopharma Ltd. |
| File Number: |
333-292528 |
|
